Notably, an increase of cytotoxic CD8 + T-lymphocytes, decrease of regulatory FOXP3 + lymphocytes and increased function of natural killer cells in tumors has been described, supporting the hypothesis that metformin may favorably alter the tumor microenvironment [9, 10, 11, 12, 39, 49]. This evidence concerns the gene CD8A and neoplasm.